EUVIMEDEUVIMED entdecken
EditorialKommentar

Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?

Ercan Yılmaz iD, Nezihe Köker Özer iD, Erdem Topal iD

Inflammatory Bowel Diseases · 02.11.2026

DOI: 10.1093/ibd/izag225 ↗

Kurz gefasst

Editorial in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 02.11.2026. Verfasst von Ercan Yılmaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Faculty of Medicine, Inonu University, Malatya, Türkiye. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pediatric Allergy and Immunology, Faculty of Medicine, Inonu University, Malatya, Türkiye.

ORCID-Profile: Ercan Yılmaz, Nezihe Köker Özer, Erdem Topal

Zitieren

APA

Yılmaz, E., Köker Özer, N., & Topal, E. (2026). Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag225

Vancouver

Yılmaz E, Köker Özer N, Topal E. Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag225

BibTeX
@article{Ylmaz2026,
  author = {Yılmaz, Ercan and Köker Özer, Nezihe and Topal, Erdem},
  title = {Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izag225}
}
Kostenlos starten →